• norsk
    • English
  • English 
    • norsk
    • English
  • Login
View Item 
  •   Home
  • Folkehelseinstituttet
  • Publikasjoner fra CRIStin FHI
  • View Item
  •   Home
  • Folkehelseinstituttet
  • Publikasjoner fra CRIStin FHI
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

The principle of delivery of T cell epitopes to antigen-presenting cells applied to peptides from influenza virus, ovalbumin, and hen egg lysozyme: Implications for peptide vaccination

Rasmussen, Ingunn B; Lunde, E.; Bogen, Bjarne; Michaelsen, Terje Einar; Sandlie, Inger
Peer reviewed, Journal article
Thumbnail
View/Open
77.+pq010296.pdf (129.2Kb)
URI
http://hdl.handle.net/11250/2507787
Date
2001
Metadata
Show full item record
Collections
  • Artikler [2944]
  • Publikasjoner fra CRIStin FHI [5073]
Original version
Proceedings of the National Academy of Sciences of the United States of America. 2001, 98 (18), 10296-10301.  
Abstract
Targeting of antigens to antigen-presenting cells (APCs) increases CD4(+) T cell activation, and this observation can be exploited in the development of new vaccines. We have chosen an antigen-targeting approach in which we make recombinant antibodies (Abs) with T cell epitopes in their constant region and APC-specific variable regions. Three commonly used model epitopes, amino acids 110-120 of hemagglutinin, 323-339 of ovalbumin, and 46-61 of hen egg lysozyme, were introduced as loops in the C(H)1 domain of human IgG3. For all three epitopes, we show that the recombinant molecules are secreted from transfected cells. The epitopes are presented to specific T cells, and targeting to IgD on B cells in vitro enhances the presentation efficiency by 10(4) to 10(5) compared with the free peptide. After i.v. injection, the epitopes targeted to IgD are presented by splenic APCs to activate specific T cells, whereas little or no activation could be detected without targeting, even after the amount of antigen injected was increased 100-fold or more. Because a wide variety of T cell epitopes, in terms of both length and secondary structure, can be tolerated in loops in constant domains of Abs, the Ab constant region seems to have the intrinsic stability that is needed for this fusion molecule strategy. It might thus be possible to load the Ab with several different epitopes in loops in different domains and thereby make a targeted multisubunit vaccine.
Journal
Proceedings of the National Academy of Sciences of the United States of America

Contact Us | Send Feedback

Privacy policy
DSpace software copyright © 2002-2019  DuraSpace

Service from  Unit
 

 

Browse

ArchiveCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsDocument TypesJournalsThis CollectionBy Issue DateAuthorsTitlesSubjectsDocument TypesJournals

My Account

Login

Statistics

View Usage Statistics

Contact Us | Send Feedback

Privacy policy
DSpace software copyright © 2002-2019  DuraSpace

Service from  Unit